Clinical Trials Browser

Phase 1 × NSCLC × 1 year × Clear all

NCT04858958 2025-11-19

FAVOUR

Phase 1 Active not recruiting

NSCLC

NCT02973763 2025-04-03

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer

Phase 1 Terminated

NSCLC